Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
CA 2453115 C · Owner: Nauwynck, Hans · Inventors: Nauwynck, Hans; Vanderheijden, Nathalie; Pensaert, Maurice
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a new polynucleotide that encodes a polypeptide involved in cellular entrance of PRRSV to a recombinant vector , comprising said polynucleotide to a cell capable of expressing said , polypeptide a method of producing said polypeptide as well as to cell culture and to a novel method of producing the PRRSV virus. The present invention further relates to a method of identifying compounds that affect the PRRSV receptor function of the polypeptide as well as to the use of the polypeptide or identified compounds in the manufacture of medicaments. The present inventors have succeeded in isolating a protein from PAM membranes that seems to play a crucial role …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 18, 2002 and granted April 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.